SWSheng Wang

Sheng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sheng Wang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Huizhen Yang

    Department of Respiratory, Zhejiang Jinhua Guangfu Cancer Hospital, Jinhua 321000, Zhejiang, China

    2 shared publications
  • Jun Song

    Respiratory Department, Zhejiang Jinhua Guangfu Cancer Hospital, Jinhua, Zhejiang, China

    2 shared publications
  • Mei Wang

    Respiratory Department, Zhejiang Jinhua Guangfu Cancer Hospital, Jinhua, Zhejiang, China

    2 shared publications
  • Xiaoyu Wu

    Department of Respiratory, Zhejiang Jinhua Guangfu Cancer Hospital, Jinhua 321000, Zhejiang, China

    2 shared publications
  • Xuzhou Yu

    Respiratory Department, Zhejiang Jinhua Guangfu Cancer Hospital, Jinhua, Zhejiang, China

    2 shared publications
  • Jiabin Chen

    The Second Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang 310012, China

    1 shared publication

Latest Publications

  • Open Access

    Investigating the causal associations between occupational noise exposure and chronic obstructive pulmonary disease: A Mendelian randomization study

    by Zhouxiao Lu, Xuzhou Yu, Mei Wang, XiaoYu Wu, Jun Song, Sheng Wang

    Occupational noise exposure (ONE) occurs frequently, but the health risk of this exposure to chronic obstructive pulmonary disease (COPD) has not been evaluated. We aimed to explore the causal role of ONE in the risk of COPD. Instrumental variables of 3 levels of ONE were included: workplace very noisy: rarely/never (cases: 51,689; control: 39,088); workplace very noisy: sometimes (cases: 69,515; control: 21,382); workplace very noisy: often (cases: 17,469; control: 73,184). A univariate Mendelian randomization (MR) analysis was performed to determine the genetic effect of ONE on the risk of COPD and lung function based on an “Inverse variance weighted (IVW)” approach. A multivariate MR was used to adjust the interfering factors. The heterogeneity, horizontal pleiotropy and Steiger directionality test were conducted to assess the robustness and reliability of MR. 12, 14, and 18 single nucleotide polymorphisms were identified as instrumental variables for 3 conditions: workplace very noisy: rarely/never, workplace very noisy: sometimes, and workplace very noisy: often, respectively. The IVW results showed frequent ONE and a higher liability of COPD in both the training set (odds ratio [OR] = 1.020, 95% confidence interval [CI] [1.008–1.032], P = .001) and the validation set (OR = 3.259, 95% CI [1.821–5.832], P = .012). Moreover, frequent ONE decreased the forced lung capacity (training set: OR = 0.879, 95% CI [0.782–0.987], P = .029; validation set: OR = 0.882, 95% CI [0.785–0.991], P = .035) and forced expiratory volume in 1-second (training set: OR = 0.828, 95% CI [0.728–0.943], P = .004; validation set: OR = 0.870, 95% CI [0.791–0.957], P = .004). The multivariate MR found the estimated role of frequent ONE on COPD was comparable to the univariate IVW estimate (OR = 1.021, 95% CI [1.008–1.032], P = .021). The study illustrated the causal association between ONE and the risk of COPD.

  • Open Access

    The role of chronic obstructive pulmonary disease mediated by immune cells on lung adenocarcinoma: A two-step, two-sample Mendelian randomization study

    by Xinyu Liu, Jing Xu, Sheng Wang

    Chronic obstructive pulmonary disease (COPD) commonly co-occurs with lung cancer, particularly lung adenocarcinoma (LUAD), suggesting a potential shared molecular mechanism and risk factors between the 2 conditions. This study aimed to explore the causal relationship between COPD and LUAD mediated by immune cells using a 2-step, 2-sample Mendelian randomization (MR) analysis. The random-effect inverse variance weighted method, which combines the Wald ratio of individual single-nucleotide polymorphisms, was employed as the primary approach for causal inference, with random-effects models utilized in the presence of heterogeneity. Mediation analysis was conducted to assess indirect effects in the pathway from COPD to LUAD. The MR analysis demonstrated that COPD increased the risk of LUAD (odds ratio = 1.180, 95% confidence interval [CI]: 1.004–1.387, P = .045). Furthermore, among 40 immune cell traits examined, 5 were associated with an elevated risk of LUAD, while 6 exhibited a detrimental effect. Importantly, the mediation MR analysis revealed that the indirect impact of COPD on LUAD was partially mediated by Activated & resting Treg cells (mediation effect: 0.010, 95% CI: 0.001–0.021; P = .047) and Activated & secreting Treg cells (mediation effect: 0.004, 95% CI: 0.001–0.008; P = .044). These findings suggest a positive association between COPD and LUAD, with a partial mediation effect through Activated & resting Treg cells and Activated & secreting Treg cells.


  • Open Access

    Investigating causal relationships between plasma proteins and lung adenocarcinoma: result from proteomics and Mendelian randomization study

    by Ruoya Lv, Jiabin Chen, Xiaoyu Wu, Kequn Chai, Jiadong Yan, Sheng Wang

    Background Plasma proteins contribute to the identification, diagnosis, and prognosis of human illnesses, which may be conducive to understanding the molecular mechanism and diagnosis of Lung adenocarcinoma (LUAD). Methods We collected plasma samples from 28 healthy individuals (H) and 56 LUAD patients and analyzed them using LC–MS/MS-based proteomics to determine differential expression plasma proteins (DEPPs). Then, the DEPPs were subjected to a two-sample Mendelian randomization (MR) study based on an “Inverse variance weighted (IVW)” approach to investigate the causal relationships between DEPPs and LUAD. Logistic regression analysis was conducted to develop a diagnostic model for LUAD. Results 317 plasma proteins were found in proteomics, and 19 DEPPs were identified. The MR study revealed that IL20RB (odds ratio (OR) = 1.600, 95% Confidence Interval (CI) [1.098, 2.331], P = 0.014) and SAA2 (OR = 1.048, 95%CI [1.012, 1.081], P = 0.017) were highly related to LUAD. A diagnostic model was established with IL20RB and SAA2. The AUC of this diagnostic model was 0.858. Conclusion Plasma IL20RB and SAA2 levels were closely connected with LUAD.


  • Open Access

    Gut microbiota was highly related to the immune status in chronic obstructive pulmonary disease patients

    by Mei Wang, Jun Song, Huizhen Yang, Xiaoyu Wu, Jin Zhang, Sheng Wang

    This study aimed to explore the profile of gut microbiota and immunological state in COPD patients. 80 fecal and blood samples were collected from 40 COPD patients and 40 healthy controls (HC) and analyzed with 16s-rRNA gene sequencing and immunofactor omics analysis to investigate the profile of gut microbiota and immunologic factors (IFs). The linear discriminant analysis (LDA) effect size (LefSe) was used to determine the biomarker’s taxa. The random forest and LASSO regression analysis were executed to screen IFs and develop an IFscore model. The correlation between gut microbiota and IFs, along with the IFscore and the diversity of gut microbiota, was evaluated with the Spearman analysis. The α and β diversity showed that the composition and distribution of gut microbiota in the COPD group differed from that of the HC group. 7 differential taxa at the phylum level and 17 differential taxa at the genus level were found. LefSe analysis screened out 5 biomarker’s taxa. 32 differential IFs (up-regulated 27 IFs and down-regulated 5 IFs) were identified between two groups, and 5 IFs (CCL3, CXCL9, CCL7, IL2, IL4) were used to construct an IFscore model. The Spearman analysis revealed that 29 IFs were highly related to 5 biomarker’s taxa and enriched in 16 pathways. Furthermore, the relationship between the IFscore and gut microbiota diversity was very close. The gut microbiota and IFs profile in COPD patients differed from that in healthy individuals. Gut microbiota was highly related to the immune status in COPD patients.


  • Open Access

    Causal relationships between gut microbiota, immune cell, and Non-small cell lung cancer: a two-step, two-sample Mendelian randomization study

    by Jiabin Chen, Xuzhou Yu, Xiao Yu Wu, Kequn Chai, Sheng Wang

    Background: Regulating the immune system is a crucial measure of gut microbiota (GM) that influences the development of diseases. The causal role of GM on Non-small cell lung cancer (NSCLC) and whether it can be mediated by immune cells is still unknown.


  • Open Access

    Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma

    by Xiaoyu Wu, Sheng Wang, Kaifang Chen

    Lung adenocarcinoma (LUAD) is the most common pathological subtype of lung cancer. Ferroptosis is an iron-dependent, non-apoptotic cell death mode, highly correlated with the tumorigenesis and progression of multiple cancers. Solute carrier family 7 member 11 (SLC7A11) maintains the anti-porter activity of cysteine and glutamate to regulate ferroptosis. We collected bulk RNA-seq and scRNA-seq from The Cancer Genome Altas and Gene Expression Omnibus databases. Then, we extracted the expression level of SLC7A11 to perform the differential expression analysis between normal tissues and LUAD tissues. Then, we applied survival, univariate, and multivariate Cox regression analyses to investigate the predictive value of SLC7A11 in LUAD. Gene set enrichment analysis was used to explore the underlying molecular mechanisms of SLC7A11 in LUAD. Finally, we analyzed the relationship of SLC7A11 to the immune status and the curative effect of immunotherapy. The expression level of SLC7A11 in LUAD tissues was markedly increased. The survival analysis, univariate and multivariate Cox regression analysis showed that SLC7A11 was a negative factor for the prognosis of LUAD patients. Gene set enrichment analysis revealed that several immune-related pathways were enriched in the low-level group. The lower SLC7A11 level has a better therapeutic effect of immunotherapy and less probability of immune escape and dysfunction. SLC7A11 was a prognostic-related biomarker and closely correlated with the immune status and therapeutic effect of immunotherapy in LUAD, which could be an effective biomarker for evaluating the prognosis and the therapeutic efficacy of immunotherapy.


  • Open Access

    The expression and prognostic value of disulfidptosis progress in lung adenocarcinoma

    by Lina Ni, Huizhen Yang, Xiaoyu Wu, Kejin Zhou, Sheng Wang

    Disulfidptosis is a new cell death model caused by accumulating intracellular disulfides bonding to actin cytoskeleton proteins. This study aimed to investigate the expression and prognostic value of disulfidptosis-related genes (DRGs) in lung adenocarcinoma (LUAD). The data of expression profiles and scRNA-seq were collected from TCGA and GEO databases. The different expressions of DRGs between normal and LUAD tissues were compared. The LASSO analysis and multivariate Cox regression analysis were utilized to develop a DRGs model for the prognosis evaluation in LUAD. The model’s predictive accuracy was evaluated with the area under the receiver operating characteristic curve (AUC) and C-index. Survival analysis, univariate and multivariate Cox regression analysis were used to assessing the predictive value of the DRGs model. ScRNA-seq data were analyzed with “Seurat” and “Monocle 2” packages. There were significant differences in 22 DRGs between normal and tumor tissues. A model with five DRGs (ACTB, FLNB, NCKAP1, SLC3A2, SLC7A11) was constructed. The AUC and C-index of the model were significantly higher than that based on clinical parameters. Survival analysis, univariate and multivariate Cox regression analysis demonstrated risk score was an independent prognostic predictor. In the scRNA-seq study, we identified 14 clusters and 11 cell types. Clusters 2, 8, and 13 were annotated into Epithelial cells. SLC7A11 and SLC3A2, NCKAP1 and FLNB, ACTB expressed most abundantly in Epithelial cells, Endothelial cells, Naive CD4 T, respectively. We explored the expression of DRGs in LUAD and constructed a predictive DRGs model, which was stable and reliable for predicting LUAD prognosis.